Details for: EIF4H

Gene ID: 7458

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: EIF4H

Ensembl ID: ENSG00000106682

Description: eukaryotic translation initiation factor 4H

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 77.65
    rCSI 70.12%
    PRS 8.19
  • extravillous trophoblast CL0008036
    CSI 63.8
    rCSI 78.92%
    PRS 8.12
  • hematopoietic stem cell CL0000037
    CSI 59.55
    rCSI 39.58%
    PRS 11.07
  • common dendritic progenitor CL0001029
    CSI 47.34
    rCSI 59.41%
    PRS 11.83
  • placental villous trophoblast CL2000060
    CSI 45.44
    rCSI 70.21%
    PRS 8.67
  • common myeloid progenitor CL0000049
    CSI 44.23
    rCSI 35.76%
    PRS 9.15
  • fraction A pre-pro B cell CL0002045
    CSI 42.29
    rCSI 48.41%
    PRS 19.16
  • granulocyte monocyte progenitor cell CL0000557
    CSI 35.31
    rCSI 30.57%
    PRS 10.33
  • intestinal epithelial cell CL0002563
    CSI 27.07
    rCSI 28.29%
    PRS 9.78
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 26.16
    rCSI 20.15%
    PRS 8.37
  • pancreatic A cell CL0000171
    CSI 25.99
    rCSI 27.23%
    PRS 9.87
  • large pre-B-II cell CL0000957
    CSI 25.96
    rCSI 74.12%
    PRS 16.32
  • enteric smooth muscle cell CL0002504
    CSI 25.32
    rCSI 36.14%
    PRS 10.48
  • keratinocyte CL0000312
    CSI 25.21
    rCSI 21.13%
    PRS 11.08
  • pancreatic acinar cell CL0002064
    CSI 24.4
    rCSI 32.43%
    PRS 10.09
  • fallopian tube secretory epithelial cell CL4030006
    CSI 19.94
    rCSI 19.2%
    PRS 9.59
  • syncytiotrophoblast cell CL0000525
    CSI 19.45
    rCSI 56.02%
    PRS 18.35
  • early lymphoid progenitor CL0000936
    CSI 19.01
    rCSI 16.7%
    PRS 10.41
  • microcirculation associated smooth muscle cell CL0008035
    CSI 18.15
    rCSI 52.55%
    PRS 10.5
  • promyelocyte CL0000836
    CSI 17.81
    rCSI 25.69%
    PRS 12.97
  • ciliated epithelial cell CL0000067
    CSI 17.17
    rCSI 15.1%
    PRS 6.71
  • plasmablast CL0000980
    CSI 16.54
    rCSI 13.02%
    PRS 11.04
  • mesodermal cell CL0000222
    CSI 16.06
    rCSI 19.28%
    PRS 9.19
  • stem cell CL0000034
    CSI 13.78
    rCSI 13.29%
    PRS 6.09
  • pro-B cell CL0000826
    CSI 13.75
    rCSI 11.39%
    PRS 9.27
  • mammary gland epithelial cell CL0002327
    CSI 12.58
    rCSI 44.14%
    PRS 16.81
  • pancreatic D cell CL0000173
    CSI 12.46
    rCSI 12.26%
    PRS 10.06
  • retina horizontal cell CL0000745
    CSI 12.34
    rCSI 18.81%
    PRS 8.67
  • endothelial cell of placenta CL0009092
    CSI 12.32
    rCSI 60.72%
    PRS 12.61
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 10.6
    rCSI 54.73%
    PRS 18.6
  • pancreatic ductal cell CL0002079
    CSI 10.58
    rCSI 20.58%
    PRS 9.44
  • basophil mast progenitor cell CL0002028
    CSI 10.55
    rCSI 56.28%
    PRS 34.55
  • epithelial cell of lung CL0000082
    CSI 10.38
    rCSI 8.6%
    PRS 8.79
  • pancreatic stellate cell CL0002410
    CSI 9.6
    rCSI 55.87%
    PRS 13.95
  • late pro-B cell CL0002048
    CSI 9.5
    rCSI 23.79%
    PRS 28.78
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 9.37
    rCSI 36.46%
    PRS 15.34
  • primitive red blood cell CL0002355
    CSI 8.83
    rCSI 47.63%
    PRS 17.61
  • colon epithelial cell CL0011108
    CSI 8.83
    rCSI 9.24%
    PRS 8.61
  • peripheral nervous system neuron CL2000032
    CSI 8.72
    rCSI 11.88%
    PRS 8.31
  • muscle cell CL0000187
    CSI 8.58
    rCSI 17.62%
    PRS 22.09
  • germinal center B cell CL0000844
    CSI 8.41
    rCSI 25.08%
    PRS 23.88
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 8.3
    rCSI 6.32%
    PRS 12.23
  • promonocyte CL0000559
    CSI 7.52
    rCSI 12.88%
    PRS 12.44
  • unswitched memory B cell CL0000970
    CSI 7.34
    rCSI 6.18%
    PRS 15.24
  • retinal ganglion cell CL0000740
    CSI 7.33
    rCSI 16.2%
    PRS 6.64
  • retinal cone cell CL0000573
    CSI 7.33
    rCSI 11.79%
    PRS 7.09
  • perivascular cell CL4033054
    CSI 7.28
    rCSI 9.96%
    PRS 10.53
  • pvalb GABAergic cortical interneuron CL4023018
    CSI 7.05
    rCSI 8.77%
    PRS 5.03
  • thymocyte CL0000893
    CSI 7.05
    rCSI 25.05%
    PRS 29.59
  • lung ciliated cell CL1000271
    CSI 6.84
    rCSI 7.91%
    PRS 6.78
  • tendon cell CL0000388
    CSI 6.5
    rCSI 16.89%
    PRS 26.64
  • stromal cell of ovary CL0002132
    CSI 6.45
    rCSI 17.73%
    PRS 15.42
  • type B pancreatic cell CL0000169
    CSI 6.32
    rCSI 14%
    PRS 8.59
  • interstitial cell of Cajal CL0002088
    CSI 6.16
    rCSI 7.84%
    PRS 10.78
  • precursor B cell CL0000817
    CSI 5.91
    rCSI 5.18%
    PRS 12.41
  • cerebral cortex GABAergic interneuron CL0010011
    CSI 5.44
    rCSI 16.04%
    PRS 11.58
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 5.37
    rCSI 10.16%
    PRS 20.33
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 5.37
    rCSI 4.96%
    PRS 16.99
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 5.14
    rCSI 10.24%
    PRS 15.54
  • naive T cell CL0000898
    CSI 5.12
    rCSI 3.57%
    PRS 13.27
  • epithelial cell CL0000066
    CSI 5.02
    rCSI 7.72%
    PRS 13.29
  • ON-bipolar cell CL0000749
    CSI 4.95
    rCSI 7.36%
    PRS 11.51
  • melanocyte CL0000148
    CSI 4.72
    rCSI 3.5%
    PRS 8.36
  • myeloid leukocyte CL0000766
    CSI 4.72
    rCSI 4.35%
    PRS 9.44
  • megakaryocyte progenitor cell CL0000553
    CSI 4.68
    rCSI 85.56%
    PRS 26.76
  • common lymphoid progenitor CL0000051
    CSI 4.57
    rCSI 6.11%
    PRS 17.76
  • memory B cell CL0000787
    CSI 4.48
    rCSI 4.42%
    PRS 37.43
  • CD16-positive, CD56-dim natural killer cell, human CL0000939
    CSI 4.47
    rCSI 2.98%
    PRS 25.15
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 4.42
    rCSI 11.92%
    PRS 11.96
  • intestinal crypt stem cell of colon CL0009043
    CSI 4.23
    rCSI 31.77%
    PRS 17.18
  • transit amplifying cell of colon CL0009011
    CSI 4.23
    rCSI 4.96%
    PRS 11.01
  • CD8-positive, alpha-beta memory T cell CL0000909
    CSI 4.12
    rCSI 4.3%
    PRS 28.84
  • amacrine cell CL0000561
    CSI 4.03
    rCSI 11.69%
    PRS 7.51
  • pre-conventional dendritic cell CL0002010
    CSI 3.98
    rCSI 52.69%
    PRS 31.24
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 3.96
    rCSI 2.34%
    PRS 12.82
  • radial glial cell CL0000681
    CSI 3.94
    rCSI 5.47%
    PRS 9.58
  • respiratory suprabasal cell CL4033048
    CSI 3.87
    rCSI 4.97%
    PRS 10.68
  • plasmacytoid dendritic cell, human CL0001058
    CSI 3.83
    rCSI 2.67%
    PRS 9.76
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 3.81
    rCSI 19.11%
    PRS 12.15
  • neural crest cell CL0011012
    CSI 3.77
    rCSI 2.98%
    PRS 6.38
  • pancreatic PP cell CL0002275
    CSI 3.77
    rCSI 15.01%
    PRS 16.35
  • eosinophil CL0000771
    CSI 3.73
    rCSI 24.51%
    PRS 24.3
  • epithelial cell of lower respiratory tract CL0002632
    CSI 3.7
    rCSI 2.87%
    PRS 8.84
  • naive thymus-derived CD8-positive, alpha-beta T cell CL0000900
    CSI 3.64
    rCSI 2.56%
    PRS 25.46
  • goblet cell CL0000160
    CSI 3.51
    rCSI 3.32%
    PRS 9.67
  • vein endothelial cell of respiratory system CL4033008
    CSI 3.45
    rCSI 23.7%
    PRS 18.22
  • naive thymus-derived CD4-positive, alpha-beta T cell CL0000895
    CSI 3.42
    rCSI 4.3%
    PRS 43.33
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 3.34
    rCSI 8.04%
    PRS 14.78
  • midzonal region hepatocyte CL0019028
    CSI 3.33
    rCSI 7.82%
    PRS 14.9
  • mucosal invariant T cell CL0000940
    CSI 3.31
    rCSI 2.67%
    PRS 17.09
  • pulmonary capillary endothelial cell CL4028001
    CSI 3.27
    rCSI 6.24%
    PRS 14.89
  • colon goblet cell CL0009039
    CSI 3.24
    rCSI 7.69%
    PRS 13.92
  • chondrocyte CL0000138
    CSI 3.19
    rCSI 5.07%
    PRS 8.03
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 3.18
    rCSI 5.43%
    PRS 19.12
  • pulmonary artery endothelial cell CL1001568
    CSI 3.17
    rCSI 4.31%
    PRS 14.24
  • conventional dendritic cell CL0000990
    CSI 3.14
    rCSI 2.62%
    PRS 28.37
  • double negative thymocyte CL0002489
    CSI 3.1
    rCSI 2.16%
    PRS 10.86
  • memory T cell CL0000813
    CSI 3.06
    rCSI 5.9%
    PRS 21.02
  • basal cell CL0000646
    CSI 2.98
    rCSI 3.99%
    PRS 10.1
  • podocyte CL0000653
    CSI 2.98
    rCSI 13.23%
    PRS 9.23
  • renal beta-intercalated cell CL0002201
    CSI -9.1
    rCSI -21.6%
    PRS 11.4%
  • L5 extratelencephalic projecting glutamatergic cortical neuron CL4023041
    CSI -4.9
    rCSI -17.5%
    PRS 5.0%
  • blood vessel endothelial cell CL0000071
    CSI -3.7
    rCSI -7.6%
    PRS 9.2%
  • renal principal cell CL0005009
    CSI -3.6
    rCSI -9.3%
    PRS 12.9%
  • regular ventricular cardiac myocyte CL0002131
    CSI -3.3
    rCSI -20.7%
    PRS 7.4%
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI -2.3
    rCSI -3.9%
    PRS 5.5%
  • follicular B cell CL0000843
    CSI -0.8
    rCSI -2.9%
    PRS 38.9%
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI -0.8
    rCSI -1.0%
    PRS 12.9%
  • neural progenitor cell CL0011020
    CSI -0.7
    rCSI -3.2%
    PRS 9.2%
  • corticothalamic-projecting glutamatergic cortical neuron CL4023013
    CSI -0.6
    rCSI -3.7%
    PRS 5.8%
  • astrocyte of the cerebral cortex CL0002605
    CSI 0.0
    rCSI -0.1%
    PRS 5.7%
  • tracheobronchial smooth muscle cell CL0019019
    CSI 0.0
    rCSI 0.1%
    PRS 12.3%
  • helper T cell CL0000912
    CSI 0.1
    rCSI 0.2%
    PRS 13.2%
  • glandular epithelial cell CL0000150
    CSI 0.1
    rCSI 0.3%
    PRS 18.2%
  • sncg GABAergic cortical interneuron CL4023015
    CSI 0.1
    rCSI 0.2%
    PRS 6.1%
  • basal cell of epithelium of trachea CL1000348
    CSI 0.2
    rCSI 1.1%
    PRS 29.2%
  • pancreatic epsilon cell CL0005019
    CSI 0.2
    rCSI 0.8%
    PRS 22.6%
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 0.2
    rCSI 0.2%
    PRS 12.9%
  • direct pathway medium spiny neuron CL4023026
    CSI 0.2
    rCSI 4.2%
    PRS 4.1%
  • mature alpha-beta T cell CL0000791
    CSI 0.2
    rCSI 0.7%
    PRS 15.9%
  • chandelier pvalb GABAergic cortical interneuron CL4023036
    CSI 0.2
    rCSI 0.6%
    PRS 6.4%
  • blood vessel smooth muscle cell CL0019018
    CSI 0.2
    rCSI 1.7%
    PRS 9.7%
  • epithelial cell of esophagus CL0002252
    CSI 0.2
    rCSI 2.2%
    PRS 34.9%
  • tracheal goblet cell CL1000329
    CSI 0.2
    rCSI 0.5%
    PRS 18.8%
  • sst GABAergic cortical interneuron CL4023017
    CSI 0.2
    rCSI 0.3%
    PRS 5.8%
  • Merkel cell CL0000242
    CSI 0.3
    rCSI 6.0%
    PRS 58.8%
  • peptic cell CL0000155
    CSI 0.3
    rCSI 2.6%
    PRS 28.3%
  • vasa recta descending limb cell CL1001285
    CSI 0.3
    rCSI 2.2%
    PRS 38.8%
  • type L enteroendocrine cell CL0002279
    CSI 0.3
    rCSI 0.5%
    PRS 18.3%
  • retinal bipolar neuron CL0000748
    CSI 0.3
    rCSI 0.5%
    PRS 6.9%
  • L6b glutamatergic cortical neuron CL4023038
    CSI 0.3
    rCSI 0.9%
    PRS 5.9%
  • enteroglial cell CL4040002
    CSI 0.3
    rCSI 1.5%
    PRS 18.3%
  • epithelial cell of nephron CL1000449
    CSI 0.3
    rCSI 2.8%
    PRS 40.0%
  • forebrain radial glial cell CL0013000
    CSI 0.3
    rCSI 1.0%
    PRS 13.8%
  • hepatocyte CL0000182
    CSI 0.3
    rCSI 0.5%
    PRS 8.7%
  • class switched memory B cell CL0000972
    CSI 0.3
    rCSI 0.2%
    PRS 15.6%
  • colon macrophage CL0009038
    CSI 0.3
    rCSI 1.5%
    PRS 19.7%
  • Hofbauer cell CL3000001
    CSI 0.4
    rCSI 0.7%
    PRS 11.5%
  • ventricular cardiac muscle cell CL2000046
    CSI 0.4
    rCSI 1.2%
    PRS 38.2%
  • T-helper 1 cell CL0000545
    CSI 0.4
    rCSI 0.6%
    PRS 26.2%
  • kidney connecting tubule epithelial cell CL1000768
    CSI 0.4
    rCSI 0.9%
    PRS 7.2%
  • melanocyte of skin CL1000458
    CSI 0.4
    rCSI 0.5%
    PRS 5.8%
  • mucous neck cell CL0000651
    CSI 0.4
    rCSI 0.6%
    PRS 15.0%
  • collagen secreting cell CL0000667
    CSI 0.4
    rCSI 2.3%
    PRS 36.6%
  • primordial germ cell CL0000670
    CSI 0.4
    rCSI 2.0%
    PRS 54.0%
  • indirect pathway medium spiny neuron CL4023029
    CSI 0.4
    rCSI 10.2%
    PRS 4.9%
  • cytotoxic T cell CL0000910
    CSI 0.4
    rCSI 2.5%
    PRS 13.9%
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 0.4
    rCSI 0.5%
    PRS 16.1%
  • prostate gland microvascular endothelial cell CL2000059
    CSI 0.5
    rCSI 10.9%
    PRS 33.2%
  • cardiac muscle cell CL0000746
    CSI 0.5
    rCSI 0.7%
    PRS 7.4%
  • paneth cell of colon CL0009009
    CSI 0.5
    rCSI 4.7%
    PRS 27.1%
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI 0.5
    rCSI 1.2%
    PRS 5.3%
  • mucus secreting cell CL0000319
    CSI 0.5
    rCSI 0.8%
    PRS 12.0%
  • foveolar cell of stomach CL0002179
    CSI 0.5
    rCSI 1.2%
    PRS 15.0%
  • enteroendocrine cell of colon CL0009042
    CSI 0.5
    rCSI 2.5%
    PRS 25.1%
  • lung goblet cell CL1000143
    CSI 0.5
    rCSI 6.1%
    PRS 31.5%
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 0.6
    rCSI 0.8%
    PRS 22.8%
  • mature B cell CL0000785
    CSI 0.6
    rCSI 0.5%
    PRS 11.4%
  • bronchial goblet cell CL1000312
    CSI 0.6
    rCSI 2.2%
    PRS 20.5%
  • near-projecting glutamatergic cortical neuron CL4023012
    CSI 0.6
    rCSI 2.1%
    PRS 5.6%
  • skeletal muscle satellite cell CL0000594
    CSI 0.6
    rCSI 1.6%
    PRS 32.9%
  • centrilobular region hepatocyte CL0019029
    CSI 0.6
    rCSI 1.5%
    PRS 15.5%
  • tissue-resident macrophage CL0000864
    CSI 0.6
    rCSI 2.8%
    PRS 21.2%
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 0.6
    rCSI 1.7%
    PRS 13.4%
  • myelocyte CL0002193
    CSI 0.6
    rCSI 4.0%
    PRS 30.6%
  • kidney loop of Henle thin ascending limb epithelial cell CL1001107
    CSI 0.7
    rCSI 1.7%
    PRS 8.7%
  • keratocyte CL0002363
    CSI 0.7
    rCSI 1.6%
    PRS 14.1%
  • elicited macrophage CL0000861
    CSI 0.7
    rCSI 0.6%
    PRS 10.6%
  • small intestine goblet cell CL1000495
    CSI 0.7
    rCSI 1.5%
    PRS 12.5%
  • fibroblast of breast CL4006000
    CSI 0.7
    rCSI 3.0%
    PRS 24.6%
  • natural T-regulatory cell CL0000903
    CSI 0.7
    rCSI 1.4%
    PRS 26.1%
  • endothelial cell of uterus CL0009095
    CSI 0.7
    rCSI 5.3%
    PRS 25.7%
  • small pre-B-II cell CL0000954
    CSI 0.7
    rCSI 0.7%
    PRS 19.6%
  • erythroid lineage cell CL0000764
    CSI 0.7
    rCSI 4.7%
    PRS 22.6%
  • stratified epithelial cell CL0000079
    CSI 0.8
    rCSI 4.7%
    PRS 40.2%
  • squamous epithelial cell CL0000076
    CSI 0.8
    rCSI 1.8%
    PRS 12.0%
  • nasal mucosa goblet cell CL0002480
    CSI 0.8
    rCSI 0.9%
    PRS 13.8%
  • endothelial cell of arteriole CL1000412
    CSI 0.8
    rCSI 4.4%
    PRS 31.5%
  • paneth cell CL0000510
    CSI 0.8
    rCSI 1.2%
    PRS 14.6%
  • intermediate monocyte CL0002393
    CSI 0.8
    rCSI 1.2%
    PRS 9.1%
  • hair follicular keratinocyte CL2000092
    CSI 0.8
    rCSI 14.4%
    PRS 37.7%
  • Langerhans cell CL0000453
    CSI 0.8
    rCSI 1.3%
    PRS 16.2%
  • endothelial cell of pericentral hepatic sinusoid CL0019022
    CSI 0.8
    rCSI 2.6%
    PRS 15.5%
  • alveolar type 1 fibroblast cell CL4028004
    CSI 0.8
    rCSI 0.9%
    PRS 10.7%
  • mesenchymal stem cell CL0000134
    CSI 0.8
    rCSI 9.2%
    PRS 16.9%
  • fast muscle cell CL0000190
    CSI 0.9
    rCSI 3.3%
    PRS 25.1%
  • corneal epithelial cell CL0000575
    CSI 0.9
    rCSI 2.4%
    PRS 17.0%
  • tracheobronchial serous cell CL0019001
    CSI 0.9
    rCSI 3.8%
    PRS 18.0%
  • alveolar macrophage CL0000583
    CSI 0.9
    rCSI 1.5%
    PRS 10.9%
  • duct epithelial cell CL0000068
    CSI 0.9
    rCSI 1.3%
    PRS 9.8%
  • lung neuroendocrine cell CL1000223
    CSI 0.9
    rCSI 1.3%
    PRS 10.6%
  • erythroblast CL0000765
    CSI 0.9
    rCSI 2.5%
    PRS 15.6%
  • megakaryocyte CL0000556
    CSI 0.9
    rCSI 4.0%
    PRS 17.0%
  • innate lymphoid cell CL0001065
    CSI 0.9
    rCSI 1.9%
    PRS 14.5%
  • lung pericyte CL0009089
    CSI 1.0
    rCSI 2.5%
    PRS 11.1%
  • CD8-alpha-alpha-positive, alpha-beta intraepithelial T cell CL0000915
    CSI 1.0
    rCSI 4.3%
    PRS 33.8%
  • T-helper 17 cell CL0000899
    CSI 1.0
    rCSI 0.8%
    PRS 16.3%
  • tuft cell of colon CL0009041
    CSI 1.0
    rCSI 2.3%
    PRS 20.8%
  • immature B cell CL0000816
    CSI 1.0
    rCSI 0.7%
    PRS 13.8%
  • glial cell CL0000125
    CSI 1.0
    rCSI 3.7%
    PRS 9.7%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [EIF4H](/details-gene/7458) (eukaryotic translation initiation factor 4H) is a protein-coding gene located on chromosome 7q11.23. As its name suggests, [EIF4H](/details-gene/7458) is a key component of the machinery that initiates protein synthesis in eukaryotes. Functionally, it is involved in the cap-dependent translation initiation pathway, where it binds RNA and modulates the activity of other initiation factors. Expression data indicates that [EIF4H](/details-gene/7458) is particularly significant in highly proliferative and metabolically active cell types, such as hematopoietic progenitors, including [megakaryocyte-erythroid progenitor cells](/details-cell/CL0000050) and [hematopoietic stem cells](/details-cell/CL0000037), as well as placental trophoblasts. This expression pattern underscores its fundamental role in processes requiring robust protein synthesis, such as cell growth, differentiation, and development. ## Cellular Roles and Expression Landscape The expression profile of [EIF4H](/details-gene/7458) strongly points to a critical role in cellular proliferation and developmental processes. **Overall**, the gene shows the highest significance in various progenitor populations, reflecting its essential function in building the cellular machinery for growth and differentiation. Its top markers are dominated by hematopoietic stem and progenitor cells, including [megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050) (CSI: 77.65), [hematopoietic stem cell](/details-cell/CL0000037) (CSI: 59.55), [common dendritic progenitor](/details-cell/CL0001029) (CSI: 47.34), and [common myeloid progenitor](/details-cell/CL0000049) (CSI: 44.23). This is consistent with the high translational demands of hematopoiesis. Beyond the hematopoietic system, [EIF4H](/details-gene/7458) is also a highly significant marker in placental cells, such as [extravillous trophoblast](/details-cell/CL0008036) (CSI: 63.80) and [placental villous trophoblast](/details-cell/CL2000060) (CSI: 45.44), which are characterized by rapid growth and extensive protein secretion essential for fetal development. The gene's importance is also noted in other active cell types like [intestinal epithelial cells](/details-cell/CL0002563) and [pancreatic acinar cells](/details-cell/CL0002064). Conversely, [EIF4H](/details-gene/7458) shows low to negative significance in terminally differentiated and less proliferative cell types. Notably, its expression is suppressed in various neuronal subtypes, such as [L5 extratelencephalic projecting glutamatergic cortical neuron](/details-cell/CL4023041) (CSI: -4.87), and specialized kidney cells like [renal beta-intercalated cell](/details-cell/CL0002201) (CSI: -9.06). This pattern of selective expression suggests that while [EIF4H](/details-gene/7458) is a core component of the translation machinery, its expression levels are tightly regulated and are particularly elevated in contexts of high translational demand, such as cell division and lineage specification. ## Pathways and Molecular Function The functional annotations for [EIF4H](/details-gene/7458) confirm its central role in protein synthesis. As a translation initiation factor ([GO:0003743](https://www.ebi.ac.uk/QuickGO/term/GO:0003743)), it possesses RNA binding capacity ([GO:0003723](https://www.ebi.ac.uk/QuickGO/term/GO:0003723)) and is a known component of the [eukaryotic translation initiation factor 4f complex](/details-component/GO0016281). Its involvement has been characterized in studies detailing its ability to modulate the helicase activity of eIF4A, a critical step in preparing mRNA for ribosomal scanning [Link](https://doi.org/10.1074/jbc.m100157200). Reactome pathway analysis places [EIF4H](/details-gene/7458) squarely within the core processes of protein metabolism. It is a participant in multiple steps of [Eukaryotic translation initiation](/details-pathway/R-HSA-72613), including [Cap-dependent translation initiation](/details-pathway/R-HSA-72737), [Activation of the mrna upon binding of the cap-binding complex and eifs, and subsequent binding to 43s](/details-pathway/R-HSA-72662), and [Ribosomal scanning and start codon recognition](/details-pathway/R-HSA-72702). These annotated functions are highly consistent with its observed expression pattern in progenitor cells, which require efficient and large-scale protein production to support rapid growth ([GO:0048589](https://www.ebi.ac.uk/QuickGO/term/GO:0048589)) and differentiation. ## Research Directions The specific enrichment of [EIF4H](/details-gene/7458) in progenitor and highly proliferative cells suggests that its regulation is a key control point in development and tissue homeostasis. Dysregulation of translation initiation is a known hallmark of cancer and developmental disorders, positioning [EIF4H](/details-gene/7458) as a gene of significant biological and potential clinical interest. **Testable Hypotheses:** 1. Given its high significance in hematopoietic progenitors, the dynamic regulation of [EIF4H](/details-gene/7458) expression is critical for hematopoietic lineage commitment. Forced overexpression may skew differentiation towards specific lineages (e.g., megakaryocyte-erythroid), while its suppression may impair self-renewal or induce quiescence in [hematopoietic stem cells](/details-cell/CL0000037). 2. The prominent expression of [EIF4H](/details-gene/7458) in [extravillous trophoblasts](/details-cell/CL0008036) and [placental villous trophoblasts](/details-cell/CL2000060) suggests it is essential for placental invasion and function. Reduced [EIF4H](/details-gene/7458) activity could lead to placental insufficiency and may be a contributing factor to pathologies such as preeclampsia or intrauterine growth restriction. **Proposed Experiment:** To test the first hypothesis regarding hematopoiesis, one could utilize a CRISPR-interference (CRISPRi) system to achieve tunable knockdown of [EIF4H](/details-gene/7458) in primary human CD34+ hematopoietic stem and progenitor cells (HSPCs). These modified HSPCs would then be cultured in vitro under conditions that promote differentiation towards erythroid, myeloid, and lymphoid lineages. The impact of varying levels of [EIF4H](/details-gene/7458) suppression on the efficiency and kinetics of lineage specification could be quantified using flow cytometry for cell surface markers and colony-forming unit (CFU) assays. Complementary RNA-sequencing at key time points would reveal the downstream transcriptional programs affected by altered translational control. **Therapeutic Potential:** As a crucial factor in a fundamental cellular process, [EIF4H](/details-gene/7458) presents a potential therapeutic target, particularly in oncology. Many cancers exhibit an addiction to high rates of protein synthesis to sustain rapid growth. Therefore, inhibition of translation initiation is a validated anti-cancer strategy. [EIF4H](/details-gene/7458) could be a target for small molecule inhibitors designed to disrupt its interaction with other initiation factors. However, because of its vital role in healthy progenitor cells, systemic inhibition would likely cause significant on-target toxicity, particularly affecting the hematopoietic and gastrointestinal systems. A viable therapeutic approach would likely require either developing highly selective inhibitors that exploit cancer-specific dependencies or utilizing advanced drug delivery systems (e.g., antibody-drug conjugates) to target inhibitors specifically to malignant cells. The therapeutic strategy would be one of inhibition.

Genular Protein ID: 3125912842

Symbol: IF4H_HUMAN

Name: Eukaryotic translation initiation factor 4H

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 8812460

Title: Identification of genes from a 500-kb region at 7q11.23 that is commonly deleted in Williams syndrome patients.

PubMed ID: 8812460

DOI: 10.1006/geno.1996.0469

PubMed ID: 11003705

Title: Comparative genomic sequence analysis of the Williams syndrome region (LIMK1-RFC2) of human chromosome 7q11.23.

PubMed ID: 11003705

DOI: 10.1007/s003350010166

PubMed ID: 7584026

Title: Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1.

PubMed ID: 7584026

DOI: 10.1093/dnares/1.1.27

PubMed ID: 14702039

Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.

PubMed ID: 14702039

DOI: 10.1038/ng1285

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 12665801

Title: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.

PubMed ID: 12665801

DOI: 10.1038/nbt810

PubMed ID: 9516461

Title: Purification and characterization of a new eukaryotic protein translation factor. Eukaryotic initiation factor 4H.

PubMed ID: 9516461

DOI: 10.1074/jbc.273.13.7579

PubMed ID: 10585411

Title: Further biochemical and kinetic characterization of human eukaryotic initiation factor 4H.

PubMed ID: 10585411

DOI: 10.1074/jbc.274.50.35415

PubMed ID: 11418588

Title: Modulation of the helicase activity of eIF4A by eIF4B, eIF4H, and eIF4F.

PubMed ID: 11418588

DOI: 10.1074/jbc.m100157200

PubMed ID: 16014927

Title: mRNA decay during herpes simplex virus (HSV) infections: protein-protein interactions involving the HSV virion host shutoff protein and translation factors eIF4H and eIF4A.

PubMed ID: 16014927

DOI: 10.1128/jvi.79.15.9651-9664.2005

PubMed ID: 15592455

Title: Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.

PubMed ID: 15592455

DOI: 10.1038/nbt1046

PubMed ID: 19413330

Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.

PubMed ID: 19413330

DOI: 10.1021/ac9004309

PubMed ID: 19690332

Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.

PubMed ID: 19690332

DOI: 10.1126/scisignal.2000007

PubMed ID: 20068231

Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.

PubMed ID: 20068231

DOI: 10.1126/scisignal.2000475

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 21406692

Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.

PubMed ID: 21406692

DOI: 10.1126/scisignal.2001570

PubMed ID: 22223895

Title: Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.

PubMed ID: 22223895

DOI: 10.1074/mcp.m111.015131

PubMed ID: 22814378

Title: N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.

PubMed ID: 22814378

DOI: 10.1073/pnas.1210303109

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 24129315

Title: Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.

PubMed ID: 24129315

DOI: 10.1074/mcp.o113.027870

PubMed ID: 25944712

Title: N-terminome analysis of the human mitochondrial proteome.

PubMed ID: 25944712

DOI: 10.1002/pmic.201400617

Sequence Information:

  • Length: 248
  • Mass: 27385
  • Checksum: D3098B7270A9CF38
  • Sequence:
  • MADFDTYDDR AYSSFGGGRG SRGSAGGHGS RSQKELPTEP PYTAYVGNLP FNTVQGDIDA 
    IFKDLSIRSV RLVRDKDTDK FKGFCYVEFD EVDSLKEALT YDGALLGDRS LRVDIAEGRK 
    QDKGGFGFRK GGPDDRGMGS SRESRGGWDS RDDFNSGFRD DFLGGRGGSR PGDRRTGPPM 
    GSRFRDGPPL RGSNMDFREP TEEERAQRPR LQLKPRTVAT PLNQVANPNS AIFGGARPRE 
    EVVQKEQE